Patent Yard Sign in
Canadian application, no grantCanada

Template molecule having broad applicability and highly efficient function means of cell-free synthesis of proteins by using the same

CA 2385134 A1 · Owner: Cellfree Sciences Co. Ltd. · Inventors: Endo, Yaeta

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A process for synthesizing an mRNA having a high translational template activity which comprises transferring a sequence having a specific sequence and a sequence structure having at least a non-translational sequence respectively into the 5'-end and 3'-end of an mRNA which is a protein translational template molecule to thereby construct an mRNA having a high translation efficiency, and constructing a plasmid having a wide applicability which contains a template DNA for transcribing the above mRNA; a purification method; a practically available means of cell-free synthesis of proteins by using the same wherein a continuous RNA synthesis means is combined with a continuous …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 13, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 13, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 13, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 13, 2000
GrantedNo grant recorded
Term endedOctober 13, 2020
Patent numberCA 2385134 A1
Classification (IPC)C12N15/10 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedOct 13, 2000Term endedOct 13, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.